Cargando…
Role of “old” pharmacological agents in the treatment of Cushing’s syndrome
Despite recent advances in the management of endogenous Cushing’s syndrome (CS), its treatment remains a challenge. When surgery has been unsuccessful or unfeasible as well in case of recurrence, the “old” pharmacological agents represent an important alternative for both ACTH-dependent and independ...
Autores principales: | Ambrogio, A. G., Cavagnini, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987391/ https://www.ncbi.nlm.nih.gov/pubmed/27086313 http://dx.doi.org/10.1007/s40618-016-0462-4 |
Ejemplares similares
-
Pharmacological management of severe Cushing’s syndrome: the role of etomidate
por: Pence, Andrea, et al.
Publicado: (2022) -
Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease
por: Ambrogio, Alberto Giacinto, et al.
Publicado: (2017) -
Variability in laboratory parameters used for management of Cushing’s syndrome
por: Pecori Giraldi, Francesca, et al.
Publicado: (2015) -
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications
por: Isidori, Andrea M., et al.
Publicado: (2015) -
Systemic therapy of Cushing’s syndrome
por: Eckstein, Niels, et al.
Publicado: (2014)